Cargando…

In Vivo Development of Aztreonam Resistance in Meropenem-Resistant Pseudomonas aeruginosa Owing to Overexpression of the bla(PDC-16)

The rapid acquisition of antibiotic resistance of Pseudomonas aeruginosa has been a complex problem in clinics. Two meropenem-resistant P. aeruginosa isolates were collected from the same patient on May 24, 2021, and June 4, 2021, respectively. The first was susceptible to aztreonam, while the secon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Li, Sun, Yue, Zhang, Yizhuo, Shen, Siquan, Hu, Fupin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269455/ https://www.ncbi.nlm.nih.gov/pubmed/37070974 http://dx.doi.org/10.1128/spectrum.03080-22

Ejemplares similares

Role of inducers in detection of bla(PDC)-mediated oxyimino-cephalosporin resistance in Pseudomonas aeruginosa
por: Ingti, Birson, et al.
Publicado: (2017)

First Report of bla(OXA-677) with Enhanced Meropenem-Hydrolyzing Ability in Pseudomonas aeruginosa in China
por: Sun, Yue, et al.
Publicado: (2021)

Association of bla(VIM-2), bla(PDC-35), bla(OXA-10,) bla(OXA-488) and bla(VEB-9) β-Lactamase Genes with Resistance to Ceftazidime–Avibactam and Ceftolozane–Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa
por: Sid Ahmed, Mazen A., et al.
Publicado: (2022)

Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa
por: Jorth, Peter, et al.
Publicado: (2017)

In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing bla(KPC) or bla(NDM)
por: Kuai, Junyang, et al.
Publicado: (2023)

A MexR Mutation Which Confers Aztreonam Resistance to Pseudomonas aeruginosa
por: Ma, Zhenzhen, et al.
Publicado: (2021)

First Report of bla(CTX–M–167), bla(SHV–1), and bla(TEM–1B) Carrying Klebsiella pneumonia Showing High-Level Resistance to Carbapenems
por: Li, Shirong, et al.
Publicado: (2022)

Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in Pseudomonas aeruginosa
por: Hassuna, Noha Anwar, et al.
Publicado: (2020)

Imipenem Resistance Mediated by bla(OXA-913) Gene in Pseudomonas aeruginosa
por: Moon, Dong-Chan, et al.
Publicado: (2021)

High prevalence of bla(VEB), bla(GES) and bla(PER) genes in beta-lactam resistant clinical isolates of Pseudomonas aeruginosa
por: Haghighi, Saboura, et al.
Publicado: (2022)

Isolation of a Ceftazidime-Avibactam-Resistant bla(KPC-71)-Positive Klebsiella pneumoniae Clinical Isolate
por: Shen, Siquan, et al.
Publicado: (2022)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

2792. Determining the activity of imipenem/relebactam (I/R) plus aztreonam (ATM) against constitutive Pseudomonas derived cephalosporinase (PDC)- and metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa in a hollow fiber infection model (HFIM)
por: O’Donnell, J Nicholas, et al.
Publicado: (2023)

In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-β-lactamase-producing Pseudomonas aeruginosa
por: Oie, Shigeharu, et al.
Publicado: (2009)

Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study
por: Gunalan, Anitha, et al.
Publicado: (2021)

Co-existence of bla(IMP), bla(NDM-1), and bla(SHV), genes of Pseudomonas aeruginosa isolated from Quetta: Antimicrobial resistance and clinical significance
por: Din, Mohammad, et al.
Publicado: (2023)

Successful treatment of multidrug-resistant Pseudomonas aeruginosa keratitis with meropenem eye drops — a case report
por: Elhardt, Carolin, et al.
Publicado: (2023)

Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections
por: Hogan, Michael, et al.
Publicado: (2018)

1601. Evaluation of Synergy with β-Lactams Plus Aztreonam Against Pseudomonas aeruginosa (PSA)
por: O’Donnell, J Nicholas, et al.
Publicado: (2019)

Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa
por: Moghoofei, Mohsen, et al.
Publicado: (2015)

Carbapenem-resistant Pseudomonas aeruginosa with acquired bla(vim) metallo-beta-lactamase determinants, Italy.
por: Rossolini, G M, et al.
Publicado: (2000)

A novel plasmid carrying carbapenem-resistant gene bla(KPC-2) in Pseudomonas aeruginosa
por: Hu, Yan-Yan, et al.
Publicado: (2019)

Molecular Detection of Drug-Resistance Genes of bla(OXA-23)-bla(OXA-51) and mcr-1 in Clinical Isolates of Pseudomonas aeruginosa
por: Nitz, Fabiana, et al.
Publicado: (2021)

Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus
por: Yim, Juwon, et al.
Publicado: (2016)

bla (KPC-2) overexpression and bla (GES-5) carriage as major imipenem/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in China
por: Li, Yue, et al.
Publicado: (2023)

1597. Ceftolozane-Tazobactam and Meropenem Synergy Testing Against Multi-Drug and Extensively-Drug Resistant Pseudomonas aeruginosa
por: Chua, Mary Francine P, et al.
Publicado: (2020)

Pseudomonas aeruginosa Coharboring Bla(KPC-2) and Bla(VIM-2) Carbapenemase Genes
por: Pacheco, Tatiana, et al.
Publicado: (2019)

First Report of bla(IMP–4) and bla(SRT–2) Coproducing Serratia marcescens Clinical Isolate in China
por: Huang, Xiangning, et al.
Publicado: (2021)

A Phage-Like Plasmid Carrying bla(KPC-2) Gene in Carbapenem-Resistant Pseudomonas aeruginosa
por: Galetti, Renata, et al.
Publicado: (2019)

Challenging T > MIC Using Meropenem vs. Escherichia coli and Pseudomonas aeruginosa
por: Nussbaumer-Pröll, A., et al.
Publicado: (2022)

Proteomic analysis of ceftazidime and meropenem-exposed Pseudomonas aeruginosa ATCC 9027
por: Ngo, Hong Loan, et al.
Publicado: (2023)

2443. Searching for the Optimal Treatment Regimen for Metallo-β-Lactamase Producing Enterobacteriaceae: Aztreonam Plus Ceftazidime–Avibactam vs. Aztreonam Plus Meropenem–Vaborbactam
por: Biagi, Mark, et al.
Publicado: (2018)

In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
por: Hu, Yi-Fan, et al.
Publicado: (2016)

Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant Pseudomonas aeruginosa and Minimize Biofilm Formation
por: Wickremasinghe, Hasini, et al.
Publicado: (2021)

2165. Assessing the Impact of Meropenem Exposure on Ceftolozane/tazobactam-resistance Development in Pseudomonas aeruginosa using in vitro Serial Passage
por: Fouad, Aliaa, et al.
Publicado: (2023)

Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring bla(NDM-1) and bla(NDM-5)
por: Terbtothakun, Pawarisa, et al.
Publicado: (2021)

Antimicrobial Resistance Patterns and Prevalence of blaPER-1 and blaVEB-1 Genes Among ESBL-producing Pseudomonas aeruginosa Isolates in West of Iran
por: Alikhani, Mohammad Yousef, et al.
Publicado: (2014)

Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa
por: Sadek, Mustafa, et al.
Publicado: (2022)

Emerging Carbapenem-Resistant Pseudomonas aeruginosa Isolates Carrying bla(IMP) Among Burn Patients in Isfahan, Iran
por: Radan, Mohsen, et al.
Publicado: (2016)

A Plasmid Carrying bla(IMP-56) in Pseudomonas aeruginosa Belonging to a Novel Resistance Plasmid Family
por: Gómez-Martínez, Jessica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i9reh3llgo26mri06pn88egr6b